Whole-Exome Sequencing Detecting a Recurrent Pathogenic Mutation, HFE p.His63Asp (H63D) in COVID-19 Patients and Its Effect on Mortality.

doi:10.24976/Discov.Med.202436186.140

Article

Whole-Exome Sequencing Detecting a Recurrent Pathogenic Mutation, HFE p.His63Asp (H63D) in COVID-19 Patients and Its Effect on Mortality.

Discovery medicine - 1 Jul 2024

Mir Rashid, Elfaki Imadeldin, Alanazi Mohammad A, Algehainy Naseh A, Altemani Faisal H, Alsayed Badr A, Mohamed Elsiddig Idriss, Mustafa Syed Khalid, Moawadh Mamdoh S, Tayeb Faris J, Alfaifi Jaber, Alatawi Sael M, Mir Mohammad Muzaffar, Ullah Mohammad Fahad

Abstract excerpt

BACKGROUND: In recent years, various coronaviruses have caused severe respiratory illnesses worldwide. For example the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections of COVID-19 outbreak in 2019 in Wuhan, China. Genome-wide association studies (GWAS) have significantly expanded our comprehension of how specific genetic variations are linked to diseases. Research has demonstrated the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Whole-Exome Sequencing Detecting a Recurrent Pathogenic Mutation, HFE p.His63Asp (H63D) in COVID-19 Patients and Its Effect on Mortality.

Abstract excerpt

Topics

Related research